Tabandeh, M.R.; Taha, A.S.; Addai Ali, H.; Razijalali, M.; Mohammadtaghvaei, N.
Type 2 Diabetes Mellitus Coincident with Clinical and Subclinical Thyroid Dysfunctions Results in Dysregulation of Circulating Chemerin, Resistin and Visfatin. Biomedicines 2023, 11, 346.
https://doi.org/10.3390/biomedicines11020346
AMA Style
Tabandeh MR, Taha AS, Addai Ali H, Razijalali M, Mohammadtaghvaei N.
Type 2 Diabetes Mellitus Coincident with Clinical and Subclinical Thyroid Dysfunctions Results in Dysregulation of Circulating Chemerin, Resistin and Visfatin. Biomedicines. 2023; 11(2):346.
https://doi.org/10.3390/biomedicines11020346
Chicago/Turabian Style
Tabandeh, Mohammad Reza, Amal Sattar Taha, Hanaa Addai Ali, Mohammad Razijalali, and Narges Mohammadtaghvaei.
2023. "Type 2 Diabetes Mellitus Coincident with Clinical and Subclinical Thyroid Dysfunctions Results in Dysregulation of Circulating Chemerin, Resistin and Visfatin" Biomedicines 11, no. 2: 346.
https://doi.org/10.3390/biomedicines11020346
APA Style
Tabandeh, M. R., Taha, A. S., Addai Ali, H., Razijalali, M., & Mohammadtaghvaei, N.
(2023). Type 2 Diabetes Mellitus Coincident with Clinical and Subclinical Thyroid Dysfunctions Results in Dysregulation of Circulating Chemerin, Resistin and Visfatin. Biomedicines, 11(2), 346.
https://doi.org/10.3390/biomedicines11020346